PRESCRIPTION DRUG MONITORING PROGRAM TRAINING AND TECHNICAL ASSISTANCE CENTER
The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at the Institute for Intergovernmental Research (IIR) provides a comprehensive array of services, support, resources, & strategies to PDMPs, federal partners and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse and diversion of prescription drugs.
News & Events
-
Drugs of Abuse: A Resource Guide, 2026 Edition
Read More September 28, 2026The Drug Enforcement Administration (DEA) released an updated publication, Drugs of Abuse: A Resource Guide, 2026 Edition. Drugs of Abuse delivers clear, scientific information about drugs in a factual, straightforward way. With the information in this guide, parents and caregivers can help their children make smart choices and avoid the consequences of drug abuse. This publication covers topics including the Controlled Substances Act and introduces drug classes including narcotics, stimulants, marijuana/cannabis, inhalants, steroids, and more. More information can be found at https://www.getsmartaboutdrugs.gov (opens in a new tab).
Download the Guide at https://www.getsmartaboutdrugs.gov/sites/default/files/2026-09/Drugs-Abuse-2026.pdf. (opens in a new tab)
-
Harold Rogers Prescription Drug Monitoring Program Meeting Presentations Posted on PDMP TTAC Website
Read More September 10, 2026The presentation material from the 2026 Harold Rogers Prescription Drug Monitoring Program Meeting have been posted on the PDMP TTAC Website under Learning > Meetings and Convenings (Virtual: PDMP TTAC (opens in a new tab))
-
LAPPA publishes Model Addressing Inhalant Use Act
Read More August 25, 2026The Legislative Analysis and Public Policy Association (LAPPA) is excited to announce publication of the Model Addressing Inhalant Use Act (opens in a new tab). The purpose of this legislation is to: (1) prohibit the sale of certain products containing inhalants to minors; (2) establish additional requirements for the sale of inhalants, including restrictions on advertising and the retail sale of nitrous oxide as well as packaging requirements; (3) establish criminal penalties related to inhalants; and (4) establish education, prevention, and treatment requirements. Regulating inhalants is complicated because many inhalants are common household substances, but doing so is growing increasingly critical as this availability and appearance of “safety” results in adolescents being the largest demographic that uses inhalants. This Model Act seeks to: (1) to implement measures to educate the public, particularly adolescents, on the dangers of inhalant use; and (2) prevent initiation into inhalant use by placing restrictions on purchasing certain products.
Our focus is to improve consistency among PDMPs, facilitate coordination between PDMPs and state and national stakeholders, increase PDMP efficiencies, measure performance and effectiveness, and promote best practices.
REQUEST PDMP TTA
Combat prescription misuse with RxCheck! Facilitate seamless data sharing among states, integrate with EHR systems, and join the nationwide PDMP movement. Developed with BJA support, RxCheck ensures secure data governance, empowering states to own and control their information.
LEARN MORE
